PapersFlow Research Brief
Silymarin and Mushroom Poisoning
Research Guide
What is Silymarin and Mushroom Poisoning?
Silymarin is a flavonolignan complex extracted from milk thistle (Silybum marianum) used as a hepatoprotective agent in liver diseases, including those potentially caused by mushroom poisoning such as amatoxin-induced hepatocellular toxicity.
Silymarin has been studied in 25,447 works focused on its role in liver disease treatment. Papers examine its antioxidant and hepatoprotective effects against toxins affecting the liver. Growth data over the past five years is not available.
Topic Hierarchy
Research Sub-Topics
Silymarin Hepatoprotective Mechanisms
This sub-topic elucidates silymarin's antioxidant, anti-fibrotic, and membrane-stabilizing actions in hepatocytes. In vitro and animal models test efficacy against toxins like amatoxin from mushrooms.
Silymarin in Amanita Mushroom Poisoning
Studies evaluate silymarin's role in blocking α-amanitin uptake and improving survival in Amanita phalloides intoxication. Case series and pharmacokinetics guide optimal dosing protocols.
Silymarin Pharmacokinetics and Bioavailability
Researchers profile absorption, silybin metabolism, and nanoparticle formulations to enhance hepatic delivery. Human trials assess inter-individual variability and food effects.
Silymarin Antioxidant Effects in Liver Disease
This sub-topic covers free radical scavenging and Nrf2 pathway activation in hepatitis and NAFLD models. RCTs measure biomarkers like ALT and lipid peroxidation in patients.
Silymarin in Hepatocellular Carcinoma
Investigations explore silymarin's anti-proliferative, apoptotic induction, and chemosensitizing effects in HCC cell lines. Preclinical data assess synergy with sorafenib.
Why It Matters
Silymarin serves as a supportive treatment for liver damage from toxins, including mushroom poisoning involving amatoxins that target hepatocytes. "Milk Thistle (Silybum marianum) for the Therapy of Liver Disease" by Flora et al. (1998) notes its centuries-long use for liver and biliary tract diseases, with increasing patient interest leading gastroenterologists to encounter it in practice (719 citations). "Hepatoprotective herbal drug, silymarin from experimental pharmacology to clinical medicine" by Pradhan and Girish (2006) highlights its application in hepatoprotection, representing a 180 million US dollar market in Germany alone for liver conditions like those from poisoning (518 citations). These applications extend to clinical settings for hepatitis and toxin-induced injury.
Reading Guide
Where to Start
"Milk Thistle (Silybum marianum) for the Therapy of Liver Disease" by Flora et al. (1998) first, as it provides historical context and clinical use of silymarin in liver diseases accessible to newcomers (719 citations).
Key Papers Explained
"Milk Thistle (Silybum marianum) for the Therapy of Liver Disease" by Flora et al. (1998) introduces clinical applications, which Saller et al. (2001) in "The Use of Silymarin in the Treatment of Liver Diseases" expands with treatment evidence; Abenavoli et al. (2010) in "Milk thistle in liver diseases: past, present, future" builds chronologically, while Surai (2015) in "Silymarin as a Natural Antioxidant: An Overview of the Current Evidence and Perspectives" details mechanisms connecting antioxidant roles.
Paper Timeline
Most-cited paper highlighted in red. Papers ordered chronologically.
Advanced Directions
Focus remains on established hepatoprotective uses in liver diseases from top-cited works, with no recent preprints or news indicating shifts in the past six to twelve months.
Papers at a Glance
| # | Paper | Year | Venue | Citations | Open Access |
|---|---|---|---|---|---|
| 1 | ACETYLORNITHINASE OF ESCHERICHIA COLI: PARTIAL PURIFICATION AN... | 1956 | Journal of Biological ... | 4.0K | ✓ |
| 2 | Milk Thistle ( Silybum marianum ) for the Therapy of Liver Dis... | 1998 | The American Journal o... | 719 | ✕ |
| 3 | The Use of Silymarin in the Treatment of Liver Diseases | 2001 | Drugs | 715 | ✕ |
| 4 | Silymarin as a Natural Antioxidant: An Overview of the Current... | 2015 | Antioxidants | 691 | ✓ |
| 5 | Milk thistle in liver diseases: past, present, future | 2010 | Phytotherapy Research | 581 | ✓ |
| 6 | Cytotoxicity, antiviral and antimicrobial activities of alkalo... | 2011 | Pharmaceutical Biology | 568 | ✓ |
| 7 | Silybin and Silymarin - New and Emerging Applications in Medicine | 2007 | Current Medicinal Chem... | 566 | ✕ |
| 8 | Milk-derived exosomes for oral delivery of paclitaxel | 2017 | Nanomedicine Nanotechn... | 521 | ✕ |
| 9 | Hepatoprotective herbal drug, silymarin from experimental phar... | 2006 | PubMed | 518 | ✕ |
| 10 | Tissue invasion and metastasis: Molecular, biological and clin... | 2015 | Seminars in Cancer Bio... | 515 | ✓ |
Frequently Asked Questions
What is silymarin?
Silymarin is a lipophilic extract from milk thistle (Silybum marianum) seeds composed of flavonolignans including silybin, silydianin, and silychristin. "Milk thistle in liver diseases: past, present, future" by Abenavoli et al. (2010) identifies it as the active complex used for liver treatment (581 citations). It functions primarily through hepatoprotective and antioxidant mechanisms.
How does silymarin protect the liver?
Silymarin provides hepatoprotection by stabilizing liver cell membranes and acting as an antioxidant. "Silymarin as a Natural Antioxidant: An Overview of the Current Evidence and Perspectives" by Surai (2015) details its properties from flavonolignans like silybin for liver remedy (691 citations). It counters oxidative stress in diseases including toxin-induced damage.
What are the applications of silymarin in liver diseases?
Silymarin treats liver diseases such as hepatitis and toxin exposures. "The Use of Silymarin in the Treatment of Liver Diseases" by Saller et al. (2001) reviews its supportive role (715 citations). "Silybin and Silymarin - New and Emerging Applications in Medicine" by Gažák et al. (2007) extends uses beyond hepatoprotection (566 citations).
What evidence supports silymarin for mushroom poisoning?
Silymarin counters amatoxin toxicity from mushrooms via hepatoprotective effects. "Hepatoprotective herbal drug, silymarin from experimental pharmacology to clinical medicine" by Pradhan and Girish (2006) discusses its efficacy against liver toxins (518 citations). Clinical use targets hepatocellular damage from such poisonings.
What is the current state of silymarin research?
Research totals 25,447 works on silymarin's liver applications. Top papers like "Milk Thistle (Silybum marianum) for the Therapy of Liver Disease" by Flora et al. (1998) show ongoing clinical interest (719 citations). No recent preprints or news cover new developments.
Open Research Questions
- ? How does silymarin specifically inhibit amatoxin uptake in hepatocytes during mushroom poisoning?
- ? What are the optimal dosing regimens for silymarin in acute liver failure from mushrooms?
- ? Can silymarin combinations enhance outcomes in severe amatoxin intoxication?
- ? What pharmacokinetic factors limit silymarin bioavailability in poisoning cases?
Recent Trends
The field includes 25,447 works with no specified five-year growth rate.
Highly cited papers from 1998-2015, such as Flora et al. with 719 citations, dominate.
1998No recent preprints or news available.
Research Silymarin and Mushroom Poisoning with AI
PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Find Disagreement
Discover conflicting findings and counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
See how researchers in Health & Medicine use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Silymarin and Mushroom Poisoning with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Medicine researchers